Companies › ETON

ETON PHARMACEUTICALS INC (ETON)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001710340 · EDGAR filings · Updated 2026-07-28

ETON PHARMACEUTICALS INC (ETON) has reported institutional ownership of 65.2%, with 116 institutional managers holding positions valued at $438.6M per the latest 13F reporting period.

Filings this week (1)

• 2026-07-28 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — 4/A filed
• 2026-07-16 — Insider transaction reported (Form 4)
• 2026-07-14 — Insider transaction reported (Form 4)
• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-07 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ETON PHARMACEUTICALS INC has 116 institutional holders and institutional ownership of 65.2%.

Insider activity

Insiders reported 20 transactions (2 buys, 10 sells) across 6 reporting insiders, with a net reported value of −$4.65M.

Related companies

MIMEDX GROUP INC (MDXG) · ALLOGENE THERAPEUTICS INC (ALLO) · MANNKIND CORP (MNKD) · ANGIODYNAMICS INC (ANGO) · ABCELLERA BIOLOGICS INC (ABCL) · DBV TECHNOLOGIES S A (DBVT)